<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effects of <z:chebi fb="0" ids="31530">edaravone</z:chebi>, a curative agent for <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e>, on singlet oxygen ((1)O2) released from activated human neutrophils were examined, and the effects were compared to those of histidine, a (1)O2 singlet oxygen scavenger </plain></SENT>
<SENT sid="1" pm="."><plain>The neutrophils, stimulated with opsonized zymosan, released (1)O2 that was detected by chemiluminescence using a (1)O2 specific probe, trans-1-(2'-methoxyvinyl)<z:chebi fb="1" ids="39106">pyrene</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="31530">Edaravone</z:chebi> dose-dependently suppressed the (1)O2 release with an IC(50) of approximately 0.3 microM, while the IC(50) of histidine was approximately 1 mM </plain></SENT>
<SENT sid="3" pm="."><plain>This (1)O2 scavenging activity of <z:chebi fb="0" ids="31530">edaravone</z:chebi> might be involved in its curative effects on <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> </plain></SENT>
</text></document>